When mid-sized Indian companies need capital that doesn't fit a neat box — too structured for plain equity, too bespoke for a bank loan — they increasingly call Piramal Alternatives, the fund-management division of the Piramal Group led by Ajay Piramal. With $1.5 billion in assets under management life-to-date, a team of 55+ investment professionals and 19 active portfolio companies, it is one of India's largest homegrown alternative-asset platforms.
Piramal Alternatives runs four distinct strategies across the capital stack. The India Resurgence Fund (IndiaRF), an equal joint venture with Bain Capital Credit, is a control-led turnaround platform investing equity and debt in mid-to-large Indian companies. The Performing Credit Fund (PCF) provides performing credit to high-growth mid-market companies — its first fund of ₹2,100 crore is fully invested across 17 companies, 13 of which have been successfully exited, while PCF II is now deploying with a three-to-four-year horizon. Growth Capital blends debt and equity instruments for growth-stage opportunities, and the India Access Fund of Funds backs top-tier Indian PE and VC managers alongside strategic co-investments.
The LP roster is institutional-grade: CPPIB, CDPQ, IFC and a global partnership with Bain Capital — relationships built over almost two decades of private-equity investing in India. Recent deployments show the range: ₹125 crore in auto-components maker JRG Automotive (PCF II's fourth investment), ₹160 crore in pharma company Saimirra Innopharm, ₹200 crore in ATM operator TSI India, ₹185 crore in healthcare revenue-cycle provider 3Gen Consulting, and ₹110 crore in contract drugmaker Biodeal Pharmaceuticals.
The firm's stated edge is "tailored capital solutions" — structuring anything from pure credit to structured investments around transformation and turnaround situations, guided by what it calls sponsor strength and institution-focused growth. All four fund vehicles are SEBI-registered Category II AIFs managed by Piramal Alternatives Private Limited. In practice, that makes the platform a useful counterparty for founders and promoters who need flexible, patient capital for capacity expansion, acquisitions or balance-sheet repair, without the one-size-fits-all terms of traditional lenders.
Piramal Alternatives also keeps one eye on the ecosystem it lends into: the India Access Fund of Funds systematically backs emerging Indian fund managers, recycling institutional capital into the country's venture and growth-equity pipeline — a quiet but meaningful flywheel for founders raising their first institutional rounds.
Why it matters for founders
Piramal Alternatives is not a classic VC — and that is precisely its value. If you run a profitable, growing mid-market company and need ₹100–200 crore of structured capital for expansion, acquisition or a turnaround, few Indian platforms offer this breadth of instruments under one roof. Approach with a clear use of proceeds and a realistic timeline: PCF-style capital is patient but disciplined, and a two-decade track record with global institutional LPs means diligence will be thorough.